Owens & Minor begins transition to ‘pure-play’ Patient Direct biz
By HME News Staff
Updated 8:52 AM CDT, Mon August 11, 2025
RICHMOND, Va. – Owens & Minor is in the final stages of selling its Products & Healthcare Services segment, says CEO Ed Pesicka.
As part of its financial results for the second quarter of 2025, the company classified the segment as discontinued operations.
“We are looking forward to concluding the sale of the business and working with a buyer who has the vision and greater flexibility to better support our customers and long-term growth,” Pesicka said. “I am excited about the opportunities ahead as we transition into a focused, pure-play Patient Direct business. Building on the momentum gained since we entered the Patient Direct space eight years ago, and supported by favorable demographic trends and meaningful scale, we are confident in our ability to lead as the market continues to evolve.”
Owens & Minor reported the following for the second quarter of 2025:
- Revenue of $681.9 million, about a 3% increase compared to the same period last year
- Loss from continuing operations, net of tax, GAAP of ($83.8 million)
- Adjusted net income from continuing operations, non-GAAP of $20.5 million
- Adjusted EBITDA, non-GAAP of $96.6 million
Comments